Paper33859653
Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.
Younas M and 17 others. Front Immunol, 2021. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy. Papers, record 33859653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33859653
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| HIV Infections | Major topic |
| HIV-1 | Major topic |
| Host-Pathogen Interactions | Major topic |
| Viremia | Major topic |
| Adult | |
| Aged | |
| Antiretroviral Therapy, Highly Active | |
| CD4-Positive T-Lymphocytes | |
| Cross-Sectional Studies | |
| Disease Management | |
| Disease Susceptibility | |
| Duration of Therapy | |
| Humans | |
| Lymphocyte Activation | |
| Middle Aged |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17076584 | Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. | PLoS Biol | 2006 | https://conductscience.org/library/papers/17076584 | PubMed |
| 2 | 24728071 | Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy. | PLoS One | 2014 | https://conductscience.org/library/papers/24728071 | PubMed |
| 3 | 21111238 | Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. | Cell | 2010 | https://conductscience.org/library/papers/21111238 | PubMed |
| 4 | 30464243 | HIV-1 Envelope Glycoproteins Induce the Production of TNF-α and IL-10 in Human Monocytes by Activating Calcium Pathway. | Sci Rep | 2018 | https://conductscience.org/library/papers/30464243 | PubMed |
| 5 | 24041790 | Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women. | J Infect Dis | 2013 | https://conductscience.org/library/papers/24041790 | PubMed |
| 6 | 28830393 | Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. | BMC Infect Dis | 2017 | https://conductscience.org/library/papers/28830393 | PubMed |
| 7 | 29807541 | Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study. | BMC Med | 2018 | https://conductscience.org/library/papers/29807541 | PubMed |
| 8 | 26888911 | Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART. | J Antimicrob Chemother | 2016 | https://conductscience.org/library/papers/26888911 | PubMed |
| 9 | 23332012 | Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. | HIV Med | 2013 | https://conductscience.org/library/papers/23332012 | PubMed |
| 10 | 28426825 | Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation. | PLoS Pathog | 2017 | https://conductscience.org/library/papers/28426825 | PubMed |
| 11 | 29950577 | Gp41 dynamically interacts with the TCR in the immune synapse and promotes early T cell activation. | Sci Rep | 2018 | https://conductscience.org/library/papers/29950577 | PubMed |
| 12 | 16199516 | Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16199516 | PubMed |
| 13 | 22715361 | Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients. | PLoS One | 2012 | https://conductscience.org/library/papers/22715361 | PubMed |
| 14 | 27660234 | Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression. | Clin Infect Dis | 2016 | https://conductscience.org/library/papers/27660234 | PubMed |
| 15 | 26452565 | Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy. | HIV Med | 2016 | https://conductscience.org/library/papers/26452565 | PubMed |
| 16 | 30821898 | Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch? | HIV Med | 2019 | https://conductscience.org/library/papers/30821898 | PubMed |
| 17 | 29940869 | Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: a multicenter retrospective cohort study from 2007 to 2015. | BMC Infect Dis | 2018 | https://conductscience.org/library/papers/29940869 | PubMed |
| 18 | 24130489 | Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24130489 | PubMed |
| 19 | 31026289 | Evolving understanding of cardiovascular, cerebrovascular and peripheral arterial disease in people living with HIV and role of novel biomarkers. A study of the Spanish CoRIS cohort, 2004-2015. | PLoS One | 2019 | https://conductscience.org/library/papers/31026289 | PubMed |
| 20 | 29932084 | Day-On, Day-Off emtricitabine, tenofovir disoproxil fumarate and efavirenz single tablet regimen (DODO) as maintenance therapy in HIV-infected patients. | Infez Med | 2018 | https://conductscience.org/library/papers/29932084 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42656593 | Genomic landscape of HIV-1 proviruses in ART-treated immunological non-responders. | Front Immunol | 2026 | https://conductscience.org/library/papers/42656593 | PubMed |
| 42374467 | Impact of HIV-1 low-level viremia on virologic and immunologic failure during antiretroviral therapy: a retrospective cohort study from 2005 to 2023 in Qinzhou City, Guangxi, China. | AIDS Res Ther | 2026 | https://conductscience.org/library/papers/42374467 | PubMed |
| 40791593 | No associations between HIV reservoir and inflammation in long-term virally suppressed dolutegravir-based ART-treated individuals. | Front Immunol | 2025 | https://conductscience.org/library/papers/40791593 | PubMed |
| 40569488 | A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era. | Curr HIV/AIDS Rep | 2025 | https://conductscience.org/library/papers/40569488 | PubMed |
| 40568740 | Higher levels of cell-associated HIV-1 RNA transcripts predict risk of viral blips: implications for clinical management and cure research. | AIDS | 2025 | https://conductscience.org/library/papers/40568740 | PubMed |
| 40335477 | BRD4 modulator ZL0580 and LEDGINs additively block and lock HIV-1 transcription. | Nat Commun | 2025 | https://conductscience.org/library/papers/40335477 | PubMed |
| 38543714 | HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch. | Viruses | 2024 | https://conductscience.org/library/papers/38543714 | PubMed |
| 38166689 | Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/38166689 | PubMed |
| 37955826 | Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure. | Curr HIV/AIDS Rep | 2023 | https://conductscience.org/library/papers/37955826 | PubMed |
| 37954593 | Low levels of peripheral blood activated and senescent T cells characterize people with HIV-1-associated neurocognitive disorders. | Front Immunol | 2023 | https://conductscience.org/library/papers/37954593 | PubMed |
| 37809059 | Soluble biomarkers of HIV-1-related systemic immune activation are associated with high plasma levels of growth factors implicated in the pathogenesis of Kaposi sarcoma in adults. | Front Immunol | 2023 | https://conductscience.org/library/papers/37809059 | PubMed |
| 37632071 | Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study. | Viruses | 2023 | https://conductscience.org/library/papers/37632071 | PubMed |
| 37569647 | Antiretroviral Treatment-Induced Galectin-9 Might Impact HIV Viremia in Addition to Contributing to Inflammaging. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569647 | PubMed |
| 37108729 | HIV Promotes Atherosclerosis via Circulating Extracellular Vesicle MicroRNAs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108729 | PubMed |
| 36907331 | Transcriptome analysis of CD4+ T cells from HIV-infected individuals receiving ART with LLV revealed novel transcription factors regulating HIV-1 promoter activity. | Virol Sin | 2023 | https://conductscience.org/library/papers/36907331 | PubMed |
| 36839593 | Controversies in the Design of Strategies for the Cure of HIV Infection. | Pathogens | 2023 | https://conductscience.org/library/papers/36839593 | PubMed |
| 36679927 | Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36679927 | PubMed |
| 35748553 | Association of Inflammatory Biomarkers and Cardiovascular Risk Scores in an Italian Cohort of HIV Positive Patient Undergoing Antiretroviral Therapy. | Curr HIV Res | 2022 | https://conductscience.org/library/papers/35748553 | PubMed |
| 35208887 | Two-Drug Regimens for HIV-Current Evidence, Research Gaps and Future Challenges. | Microorganisms | 2022 | https://conductscience.org/library/papers/35208887 | PubMed |
Genes29
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33859653
GET https://conductscience.org/api/papers/v1/33859653/references?page=2